Abstract:Consumption of fructose has risen markedly in recent decades owing to the use of sucrose and high-fructose corn syrup in beverages and processed foods<a href="/articles/s41586-020-2101-7#ref-CR1">1</a>, and this has contributed to increasing rates of obesity and non-alcoholic fatty liver disease<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-020-2101-7#ref-CR4">4</a>. Fructose intake triggers de novo lipogenesis in the liver<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="/articles/s41586-020-2101-7#ref-CR6">6</a>, in which carbon precursors of acetyl-CoA are converted into fatty acids. The ATP citrate lyase (ACLY) enzyme cleaves cytosolic citrate to generate acetyl-CoA, and is upregulated after consumption of carbohydrates<a href="/articles/s41586-020-2101-7#ref-CR7">7</a>. Clinical trials are currently pursuing the inhibition of ACLY as a treatment for metabolic diseases<a href="/articles/s41586-020-2101-7#ref-CR8">8</a>. However, the route from dietary fructose to hepatic acetyl-CoA and lipids remains unknown. Here, using in vivo isotope tracing, we show that liver-specific deletion of Acly in mice is unable to suppress fructose-induced lipogenesis. Dietary fructose is converted to acetate by the gut microbiota<a href="/articles/s41586-020-2101-7#ref-CR9">9</a>, and this supplies lipogenic acetyl-CoA independently of ACLY<a href="/articles/s41586-020-2101-7#ref-CR10">10</a>. Depletion of the microbiota or silencing of hepatic ACSS2, which generates acetyl-CoA from acetate, potently suppresses the conversion of bolus fructose into hepatic acetyl-CoA and fatty acids. When fructose is consumed more gradually to facilitate its absorption in the small intestine, both citrate cleavage in hepatocytes and microorganism-derived acetate contribute to lipogenesis. By contrast, the lipogenic transcriptional program is activated in response to fructose in a manner that is independent of acetyl-CoA metabolism. These data reveal a two-pronged mechanism that regulates hepatic lipogenesis, in which fructolysis within hepatocytes provides a signal to promote the expression of lipogenic genes, and the generation of microbial acetate feeds lipogenic pools of acetyl-CoA.

High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate

Fructose promotes liver cancer via microbial acetate-induced O-GlcNAcylation

Targeting Intestinal Transporter Glut5 to Prevent the High Fructose-Induced Steatotic Liver Disease

Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice

The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease

The effect of fructose exposure on amino acid metabolism among Chinese community residents and its possible multi-omics mechanisms

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma

High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism

A High-Fat and High-Fructose Diet Exacerbates Liver Dysfunction by Regulating Sirtuins in a Murine Model

Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis

A High-Fat High-Fructose Diet Dysregulates the Homeostatic Crosstalk Between Gut Microbiome, Metabolome, and Immunity in an Experimental Model of Obesity

Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification

Fructose induces hepatic steatosis in adolescent mice linked to the disorders of lipid metabolism, bile acid metabolism, and autophagy

Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma

Impact of a long-term high-fructose diet on systemic metabolic profiles of mice

A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease

Molecular Mechanisms of Metabolic Syndrome Induced by High Fructose Diet: A Review

Fructose stimulated de novo lipogenesis is promoted by inflammation

Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate

Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis